UnitedHealth Group Incorporated UNH

FY2025 · ended Dec 31, 2025 · Revenue $447.57B, +11.8% YoY · Filed Mar 2, 2026

UnitedHealth Group Incorporated (UNH) files with the SEC under industry code 6324, Hospital & Medical Service Plans. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $447.6 billion and net income of $12.1 billion. Free cash flow was $16.1 billion. As of Sep 30, 2026 it held $86.6 billion in cash and investments and $68.7 billion in total debt.

Revenue (TTM)
$449.66B
+3.3% vs year-ago TTM
Net income (TTM)
$15.88B
-9.7% vs year-ago TTM
Operating cash flow (TTM)
$26.20B
+25.0% vs year-ago TTM
Free cash flow (TTM)
$22.83B
+31.4% vs year-ago TTM
EPS (TTM)
$17.52
-8.8% vs year-ago TTM
Dividend per share (TTM)
$9.06
+5.1% vs year-ago TTM
Shares outstanding
907.68M
-0.8% vs prior year
Net cash
$17.90B
as of Sep 30, 2026
Operating margin
5.3%
FY 2026

Company profile

Industry
Hospital & Medical Service Plans (SIC 6324)
Listed as
UNH (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Eden Prairie, MN
SEC filer status
Large accelerated filer
SEC CIK
731766
Former names
UNITED HEALTHCARE CORP (until Feb 14, 2000)

Other Hospital & Medical Service Plans companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$447.6B
$400.3B
$371.6B
$324.2B
$287.6B
Operating income
$19.0B
$32.3B
$32.4B
$28.4B
$24.0B
Net income
$12.1B
$14.4B
$22.4B
$20.1B
$17.3B
Diluted EPS
$13.23
$15.51
$23.86
$21.18
$18.08
Operating cash flow
$19.7B
$24.2B
$29.1B
$26.2B
$22.3B
Free cash flow
$16.1B
$20.7B
$25.7B
$23.4B
$19.9B
Total assets
$309.6B
$298.3B
$273.7B
$245.7B
$212.2B
Total liabilities
$207.9B
$195.7B
$174.8B
$159.4B
$135.7B
Stockholders' equity
$100.1B
$98.3B
$94.4B
$81.5B
$75.0B
Cash and investments
$82.4B
$81.5B
$77.2B
$71.6B
$67.0B
Total debt
$82.3B
$81.1B
$66.4B
$61.6B
$44.6B

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 13, 2026 Oct 13, 2026
8-K Current report
Regulation FD disclosure
Sep 8, 2026 Sep 8, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 16, 2026 Jul 16, 2026
8-K Current report
Shareholder vote results
Jun 5, 2026 Jun 1, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.